Insider Trading & Ownership of KENNETH BATE

Location: Cambridge, MA
Summary: The estimated net worth of KENNETH BATE is at least $1,318,396 dollars as of 07 Nov 2025. KENNETH BATE is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.29M. KENNETH BATE is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K. KENNETH BATE is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.6K.
Signature: /s/ Mardi Dier, as Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when KENNETH BATE files a new Insider Trading report.

Ownership of KENNETH BATE

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
MDGL	MADRIGAL PHARMACEUTICALS, INC.	Director	$1,289,808	-$18,808,122	-94%	05 Nov 2025
EPZM	Epizyme, Inc.	Director	$22,963			12 Aug 2022
AVEO	AVEO PHARMACEUTICALS, INC.	Director	$5,625			19 Jan 2023
ATXS	Astria Therapeutics, Inc.	Director				11 Jun 2025
GNCA	GENOCEA BIOSCIENCES, INC.	Director				01 Jul 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.